The efficacy of SSP (Silver Spike Point) therapy for refractory urinary incontinence

The efficacy of SSP (Silver Spike Point) therapy for refractory urinary incontinence - The efficacy of SSP (Silver Spike Point) therapy for refractory urinary incontinence

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041660

Enrollment

Registered

2020-09-04

Start date

2020-09-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory urinary incontinence

Interventions

SSP therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with refractory urinary incontinence

Exclusion criteria

Exclusion criteria: The women who are pregnant or who may be pregnant and so on

Design outcomes

Primary

Measure	Time frame
The amount of change from baseline in total points on the Overactive Bladder Symptom Score	—

Countries

Japan

Contacts

Public ContactKanya Kaga

Dokkyo Medical University Hospital Department of Urology, Continence Center

k-kaga@dokkyomed.ac.jp0282-86-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026